VP Investor Relations

Job Summary:

Reporting directly to the Chief Financial Officer, the Vice President of Investor Relations will lead the activities of all investor relations matters, including engagement with analysts and investors across multiple platforms, including corporate presentations, company website, investor events, non-deal roadshows, investor, and analyst calls, press releases and earnings call scripts, and annual and quarterly SEC filings. The successful candidate will partner with the Chief Executive Officer and Chief Financial Officer to drive the company’s strategy, messaging, and positioning, with a deep understanding of the broader industry trends and competitive landscape. The VP of Investor Relations will develop a deep understanding of the company’s clinical development milestones, market differentiation opportunities, and key financial metrics. In addition to having established external relationships, the successful candidate will own the day-to-day development and nurturing of existing and new investor and analyst relationships to support the company’s strategic objectives and investor community needs. The successful candidate will evolve and lead an IR capability that thoughtfully, proactively, and credibly drives engagement with the investor community, provides insight and influence on the executive leadership team, and adds value to the overall business strategy.

This role will be able to clearly articulate the company’s positioning and differentiated approach and will balance near-term commitments and long-term options for driving value in creating the organization’s IR strategy. This role will collaborate cross-functionally internally with executives, clinical development, and functional leaders. This leader will be expected to take a highly collaborative, iterative, and dynamic approach to the execution of the IR function. A flexible yet disciplined approach with scientific fluency and the ability to make connections to company-level strategy and the external macro-environment is critical. The successful candidate will need to bring investor and market-savvy expertise to the role in order to optimally position the company now and in the future. The VP of Investor Relations will have accountability for all investor relations deliverables including investor and analyst communications and content, and as needed for press releases, SEC filings, and board of director materials.

Key Responsibilities: 

• Define and implement a strategic investor relations approach that clearly articulates the positioning and differentiation in the marketplace including the scientific attributes of batoclimab, competitive differentiation, clinical development roadmap, and financial plan.
• Bring existing relationships and further develop relationships with the analyst and shareholder community, driving appropriate interaction and communication with existing and potential investors elevating awareness and credibility of the Company’s story
• Build analyst and investor intelligence and targeting strategies to increase the company’s positioning, awareness, and relevance externally with a goal to increase coverage by respected firms and further grow our high-quality investor base.
• Serve as the primary interface with buy- and sell-side analysts and investors, and drive the optimization of executive leaders’ role in market interactions increasing opportunities for high-value exposure externally
• Develop investor messaging/marketing communication in alignment with the business capital strategy, including relative to potential capital raises, business development opportunities, or other financing strategies.
• Constantly gather intelligence on the marketplace, and inform, educate, and coach the company’s senior leadership regarding the investor and competitive landscape, providing insight on the potential impact of these market external forces on the company’s business opportunities.
• Provide executive team and board members at the company with accurate and timely updates of the company’s positioning with analysts and key shareholders, as well as overall market trends in the biotech investor community.
• Lead strategic communications development such as preparing presentation decks and creating management Q&A and conference call scripts. Additionally, provide insight on disclosure messaging and participate in the creation of the annual report and earnings releases. 
• Ensure consistency and alignment of the company’s messaging and participation at investor conferences and meetings, financial filings, and internal communications.
• Own and optimize relationships with external IR advisory services, use of external market and competitive intelligence tools, and vendors supporting IR content development and events.
• Partner with CFO on the communications with and support of the Board of Directors as it relates to external communications and IR broadly.

Qualifications:

The ideal candidate will be a strategic and proactive leader, with strong financial acumen and familiarity and comfort with clinical and scientific concepts. The ideal candidate will bring biotech/biopharma industry experience, including existing relationships and credibility with investors/analysts. The ideal candidate will establish the investor relations cadence and strategy for the business. The successful candidate will be a positive, roll-up-the-sleeves leader.

The VP of Investor Relations will have outstanding written and oral communication and interpersonal skills that will enable her or him to credibly serve as a primary representative for the company. This candidate will also be able to disagree, face confrontation, and introduce new concepts with tact, diplomacy, a sense of gravitas, and executive presence that allow for productive and influential conversations.

The VP of Investor Relations will display intellectual curiosity and horsepower that will enable the understanding of critical business drivers and the complexities of the evolving biotech landscape.  

Requirements:

• Bachelor’s degree required; advanced finance degree desirable, advanced science degree strongly preferred
• 10+ years of experience in the biotechnology/pharmaceutical industry with a focus on investor relations, finance, equity research, and/or investment banking
• Experience in having led public capital raises
• Established relationships and credibility with the investment community
• Ability to operate both at a deep level of detail and at the executive level
• Ability to manage multiple tasks and competing priorities amid ambiguity and an ability to thrive working in a fast-paced, innovative environment
• High intrinsic motivation and roll-up-the-sleeves mentality with the ability to work independently and problem solve
• A sense of accountability and an ability to anticipate and respond quickly to emerging information
• Ability to digest and effectively communicate complex scientific and clinical data to the investment community
• Ability to assess challenging dynamics, articulate options, and evaluate risks/benefits